Announcement on Changing Signatory Certified Public Accountant
Filed with SSE · · 2 pages · Chinese
Lionco Pharmaceutical Group Co., Ltd. on 6ix
Earlier from Lionco Pharmaceutical
- Announcement on Release of Pledge of Partial Shares of Controlling Shareholders
- Announcement on Resolutions of the 6th Meeting of the 5th Board of Directors
- Earnings Preannouncement for 2025
- Announcement on ""Corporate Value and Return Enhancement"" Action Plan
- Announcement on Resolutions of the 3rd Extraordinary General Meeting in 2025
Later from Lionco Pharmaceutical
- Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
- Announcement on the Reply to the Inquiry Letter Regarding Matters Relating to the Earnings Forecast of Lionco Pharmaceutical Group Co., Ltd.
- Announcement on Conversion Result of Convertible Bonds and Share Changes
- Announcement on Cancellation of Repurchased Shares Without Adjustment of Conversion Price for Convertible Bonds
- Announcement on Postponing Disclosure of 2025 Annual Report and Report for Q1 2026
Follow Lionco Pharmaceutical into a list and get an email when it puts out news.
Follow Lionco Pharmaceutical